Fatal outcome of a hepatitis B virus transfusion-transmitted infection

Vox Sanguinis

Volumn 98, Issue 4, 2010, Pages 504-507

  Niederhauser, C ^a   Weingand, T ^b   Candotti, D ^c   Maier, A ^b   Tinguely, C ^a   Wuillemin, W A ^e   Gowland, P ^a   Allain, J P ^d   Stolz, M ^a  

^a Blood Transfusion Service SRC Berne   (Switzerland)

^b Blood Transfusion Service SRC Central Switzerland   (Switzerland)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

Hepatitis B virus; High sensitive NAT assays; Low viral load; Transfusion transmitted infection

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LAMIVUDINE; VIRUS DNA;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD DONOR; CASE REPORT; DONOR SELECTION; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FATALITY; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION COMPLICATION; INFECTION PREVENTION; MALE; MYELODYSPLASTIC SYNDROME; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; RECIPIENT; SENSITIVITY ANALYSIS; SEROCONVERSION; VIRUS DETECTION; VIRUS LOAD; VIRUS TRANSMISSION; BLOOD TRANSFUSION; TRANSMISSION; VERY ELDERLY;

AGED, 80 AND OVER; BLOOD TRANSFUSION; FATAL OUTCOME; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE;

EID: 77951106106     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2009.01304.x     Document Type: Article

References (15)

1. Niederhauser C, Graziani M, Stolz M, Tinguely C, Mansouri Taleganhi B, Schneider P : Blood donor screening: how to decrease the risk of transfusion transmitted Hepatitis B Virus? Swiss Med Wkly 2008 138 : 134 141
2. Allain JP : Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004 86 : 83 91
3. Roth WK, Seifried E : The German experience with NAT. Transfus Med 2002 12 : 255 258
4. Minegishi K, Yoshikawa A, Kishimoto S, Yugi H, Yokoya N, Sakurada M, Kiyokawa H, Nishioka K, the Japanese Red Cross NAT Screening Research Group : Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening. Vox Sang 2003 84 : 287 291
5. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M, Polish Blood Transfusion Service Viral Study Group : Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology 2006 44 : 1666 1674
6. Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group : Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion 2008 48 : 2205 2213
7. Zahn A, Li C, Danso K, Candotti D, Owusu-Ofori S, Temple J, Allain JP : Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol 2008 89 : 409 418
8. Gerlich WH, Wagner FF, Chudy M, Harritshoj LH, Lattermann A, Wienzek S, Glebe D, Saniewski M, Schüttler CG, Wend UC, Willems WR, Bauerfeind U, Jork C, Bein G, Platz P, Ullum H, Dickmeiss E : HBsAg non-reactive HBV infection in blood donors: transmission and pathogenicity. J Med Virol 2007 79 : S32 S36
9. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K : Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007 47 : 1197 1205
10. Komiya Y, Katayama K, Yugi H, Mizui M, Matsukura H, Tomoguri T, Miyakawa Y, Tabuchi A, Tanaka J, Yoshizawa H : Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C. Transfusion 2008 48 : 286 294
11. Tabuchi A, Tanaka J, Katayama K, Mizui M, Matsukura H, Yugi H, Shimada T, Miyakawa Y, Yoshizawa H : Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes. J Med Virol 2008 80 : 2064 2068
12. Hsia CC, Purcell RH, Farshid M, Lachenbruch PA, Yu MW : Quantification of hepatitis B virus genomes and infectivity in human serum samples. Transfusion 2006 46 : 1829 1835
13. Llewelyn C, Williamson L : Immunodeficiency and Recipients of Blood Transfusion.
14. Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP : Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008 48 : 1022 1025
15. Gerlich WH : Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol 2006 36 (Suppl. 1 S18 S22.